Skip to Content

Waters Corp

WAT: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$556.00XjrtkGzfjfhtn

Waters Earnings: Weakness in China Cuts Into Results and 2023 Outlook, but Early Rebound Signs Seen

Wide-moat Waters reported weak second-quarter results, as biopharmaceutical clients in China reined in spending on its tools, causing management to push down its sales and adjusted EPS guidance for 2023. However, at first glance, this further reset of 2023 expectations does not materially affect our $323 fair value estimate, and Waters management highlighted some early signs of a rebound to which shares are reacting positively.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of WAT so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center